Correlation Between Day One and Voyager Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Voyager Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Voyager Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Voyager Therapeutics, you can compare the effects of market volatilities on Day One and Voyager Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Voyager Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Voyager Therapeutics.

Diversification Opportunities for Day One and Voyager Therapeutics

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Day and Voyager is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Voyager Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Voyager Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Voyager Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Voyager Therapeutics has no effect on the direction of Day One i.e., Day One and Voyager Therapeutics go up and down completely randomly.

Pair Corralation between Day One and Voyager Therapeutics

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.69 times more return on investment than Voyager Therapeutics. However, Day One Biopharmaceuticals is 1.44 times less risky than Voyager Therapeutics. It trades about -0.1 of its potential returns per unit of risk. Voyager Therapeutics is currently generating about -0.17 per unit of risk. If you would invest  1,433  in Day One Biopharmaceuticals on August 24, 2024 and sell it today you would lose (99.00) from holding Day One Biopharmaceuticals or give up 6.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Voyager Therapeutics

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Voyager Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Voyager Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Day One and Voyager Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Voyager Therapeutics

The main advantage of trading using opposite Day One and Voyager Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Voyager Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyager Therapeutics will offset losses from the drop in Voyager Therapeutics' long position.
The idea behind Day One Biopharmaceuticals and Voyager Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Directory
Find actively traded commodities issued by global exchanges